The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 5,250 | 367,100 | SH | Call | SOLE | 367,100 | 0 | 0 | |
ADOBE SYSTEMS INCORPORATED | COM | 00724F101 | 222,405 | 392,207 | SH | SOLE | 392,207 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 12,212 | 2,571,000 | SH | SOLE | 2,571,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 38,700 | 1,177,374 | SH | SOLE | 1,177,374 | 0 | 0 | ||
ALIGHT INC | COM CL A | 01626W101 | 84,426 | 7,810,000 | SH | SOLE | 7,810,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 3,956 | 265,116 | SH | SOLE | 265,116 | 0 | 0 | ||
AMAZON COM INC | COM | 023135106 | 360,209 | 108,030 | SH | SOLE | 108,030 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 9,551 | 1,057,735 | SH | SOLE | 1,057,735 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 165,290 | 1,243,810 | SH | SOLE | 1,243,810 | 0 | 0 | ||
ANALOG DEVICES INC | COM | 032654105 | 144,010 | 819,310 | SH | SOLE | 819,310 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 22,845 | 245,800 | SH | SOLE | 245,800 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,960 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM | 08205P100 | 2,015 | 769,000 | SH | SOLE | 769,000 | 0 | 0 | ||
BLOCK INC | CL A | 852234103 | 69,447 | 429,984 | SH | SOLE | 429,984 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 10,928 | 2,230,250 | SH | SOLE | 2,230,250 | 0 | 0 | ||
CANO HEALTH INC | *W EXP 06/03/202 | 13781Y111 | 1,612 | 674,566 | SH | SOLE | 674,566 | 0 | 0 | ||
CANO HEALTH INC | COM CL A | 13781Y103 | 87,968 | 9,872,990 | SH | SOLE | 9,872,990 | 0 | 0 | ||
CARVANA CO | CL A | 146869102 | 99,161 | 427,807 | SH | SOLE | 427,807 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 17,789 | 2,766,619 | SH | SOLE | 2,766,619 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 20,346 | 1,247,468 | SH | SOLE | 1,247,468 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 19,452 | 1,218,792 | SH | SOLE | 1,218,792 | 0 | 0 | ||
COPART INC | COM | 217204106 | 46,244 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 72,448 | 220,200 | SH | SOLE | 220,200 | 0 | 0 | ||
DECIBEL THERAPEUTICS INC | COM | 24343R106 | 1,226 | 263,600 | SH | SOLE | 263,600 | 0 | 0 | ||
DECKERS OUTDOOR CORP | COM | 243537107 | 79,207 | 216,230 | SH | SOLE | 216,230 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 10,377 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 1,815 | 106,000 | SH | SOLE | 106,000 | 0 | 0 | ||
ETSY INC | COM | 29786A106 | 26,745 | 122,158 | SH | SOLE | 122,158 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 19 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 976 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | *W EXP 03/06/202 | G3167F128 | 60 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | CLASS A ORD SHS | G3167F102 | 2,907 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 30,841 | 2,519,700 | SH | SOLE | 2,519,700 | 0 | 0 | ||
FINSERV ACQUISITION CORP II | *W EXP 02/17/202 | 31809Y111 | 169 | 273,149 | SH | SOLE | 273,149 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 17 | 29,166 | SH | SOLE | 29,166 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 853 | 87,498 | SH | SOLE | 87,498 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 42,024 | 2,375,571 | SH | SOLE | 2,375,571 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 6,903 | 2,372,267 | SH | SOLE | 2,372,267 | 0 | 0 | ||
GFL ENVIRONMENTAL INC | SUB VTG SHS | 36168Q104 | 175,133 | 4,627,040 | SH | SOLE | 4,627,040 | 0 | 0 | ||
GRAB HOLDINGS LIMITED | CLASS A ORD | G4124C109 | 14,260 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 22,700 | 2,486,340 | SH | SOLE | 2,486,340 | 0 | 0 | ||
HILTON WORLDWIDE HLDGS INC | COM | 43300A203 | 93,441 | 599,022 | SH | SOLE | 599,022 | 0 | 0 | ||
IMMUNEERING CORP | CLASS A COM | 45254E107 | 3,234 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 15,637 | 3,285,000 | SH | SOLE | 3,285,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 6,910 | 1,013,216 | SH | SOLE | 1,013,216 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 29,461 | 1,081,532 | SH | SOLE | 1,081,532 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 65,527 | 1,251,946 | SH | SOLE | 1,251,946 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 157,931 | 559,760 | SH | SOLE | 559,760 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 23,104 | 1,746,300 | SH | SOLE | 1,746,300 | 0 | 0 | ||
KBR INC | COM | 48242W106 | 32,644 | 685,500 | SH | SOLE | 685,500 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 23,574 | 1,409,956 | SH | SOLE | 1,409,956 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 50,014 | 3,572,419 | SH | SOLE | 3,572,419 | 0 | 0 | ||
LAUDER ESTEE COS INC | CL A | 518439104 | 166,353 | 449,360 | SH | SOLE | 449,360 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 31,349 | 2,638,775 | SH | SOLE | 2,638,775 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 25,195 | 1,467,368 | SH | SOLE | 1,467,368 | 0 | 0 | ||
MARRIOTT INTL INC NEW | CL A | 571903202 | 81,569 | 493,640 | SH | SOLE | 493,640 | 0 | 0 | ||
MASTERCARD INCORPORATED | CL A | 57636Q104 | 89,927 | 250,270 | SH | SOLE | 250,270 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 821 | 34,600 | SH | SOLE | 34,600 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 14,627 | 9,142,067 | SH | SOLE | 9,142,067 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 290,917 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 5,576 | 851,291 | SH | SOLE | 851,291 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 59,085 | 402,789 | SH | SOLE | 402,789 | 0 | 0 | ||
MOLECULAR PARTNERS AG | ADS | 60853G106 | 7,672 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 109,841 | 1,143,700 | SH | SOLE | 1,143,700 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 59,411 | 636,160 | SH | SOLE | 636,160 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 3,808 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 2,931 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 90,129 | 6,168,996 | SH | SOLE | 6,168,996 | 0 | 0 | ||
OPY ACQUISITION CORP I | UNIT 09/22/2026 | 671005205 | 2,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 6,478 | 440,696 | SH | SOLE | 440,696 | 0 | 0 | ||
OTIS WORLDWIDE CORP | COM | 68902V107 | 216,332 | 2,484,580 | SH | SOLE | 2,484,580 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 5,570 | 2,678,115 | SH | SOLE | 2,678,115 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 11,908 | 827,540 | SH | SOLE | 827,540 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 14,968 | 2,672,863 | SH | SOLE | 2,672,863 | 0 | 0 | ||
QUANTA SVCS INC | COM | 74762E102 | 133,351 | 1,163,015 | SH | SOLE | 1,163,015 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 4,885 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
RH | COM | 74967X103 | 133,942 | 249,920 | SH | SOLE | 249,920 | 0 | 0 | ||
RIVIAN AUTOMOTIVE INC | COM CL A | 76954A103 | 52,657 | 507,830 | SH | SOLE | 507,830 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 6,870 | 681,528 | SH | SOLE | 681,528 | 0 | 0 | ||
ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 78,396 | 1,967,273 | SH | SOLE | 1,967,273 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 7,629 | 5,914,000 | SH | SOLE | 5,914,000 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 11,003 | 6,287,193 | SH | SOLE | 6,287,193 | 0 | 0 | ||
SORRENTO THERAPEUTICS INC | COM NEW | 83587F202 | 492 | 105,744 | SH | SOLE | 105,744 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 36,274 | 2,437,795 | SH | SOLE | 2,437,795 | 0 | 0 | ||
TAPESTRY INC | COM | 876030107 | 184,627 | 4,547,460 | SH | SOLE | 4,547,460 | 0 | 0 | ||
TE CONNECTIVITY LTD | SHS | H84989104 | 61,732 | 382,623 | SH | SOLE | 382,623 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 8,758 | 1,238,800 | SH | SOLE | 1,238,800 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 180,468 | 270,470 | SH | SOLE | 270,470 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 45 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 1,964 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 40,804 | 485,242 | SH | SOLE | 485,242 | 0 | 0 | ||
UNION PAC CORP | COM | 907818108 | 203,564 | 808,020 | SH | SOLE | 808,020 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 229,373 | 456,790 | SH | SOLE | 456,790 | 0 | 0 | ||
WARBY PARKER INC | CL A COM | 93403J106 | 34,147 | 733,402 | SH | SOLE | 733,402 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 21,618 | 692,000 | SH | SOLE | 692,000 | 0 | 0 |